Canadian startup Opalia has secured C$3.2 million ($2.3 million) in fresh funding to scale its cell-based milk platform and accelerate efforts toward regulatory approval in North America, marking a significant step in the commercialization of lab-grown dairy. (Green Queen)
The funding comes shortly after Opalia signed its first commercial supply agreement with Dutch dairy giant Hoogwegt, signaling early industry validation for cell-based dairy solutions. (Green Queen) The company is now focusing on scaling production capabilities while advancing regulatory filings to enable market entry, with approvals seen as the next critical milestone for commercial rollout.
Opalia’s technology uses cultured mammary cells to produce milk components without cows, aiming to replicate full milk composition—including proteins, fats, and lactose—while addressing supply chain constraints and sustainability challenges in traditional dairy.
The development reflects a broader shift in the global dairy landscape, where rising demand, climate pressures, and supply volatility are driving investment into alternative dairy technologies. However, regulatory approval and consumer acceptance remain key hurdles, with commercialization timelines dependent on navigating complex food safety frameworks across markets.
The funding milestone positions Opalia among emerging players attempting to redefine dairy production, as the industry explores scalable, sustainable alternatives alongside conventional systems.
Source: Dairynews7x7 29 April, 2026 Read full story here
#CellBasedDairy #AltDairy #FoodTech #DairyInnovation #SustainableDairy #FutureOfFood #Dairynews7x7